#1 Lawyer Network
Slaughter and May has bagged a role alongside four US and Swiss firms on Johnson & Johnson’s $30bn acquisition of Actelion.
Pharmaceutical manufacturer Johnson & Johnson turned to US firm Cravath Swaine & Moore, which fielded a team led by partners Robert Townsend and Damien Zoubek.
Homburger advised the company in Switzerland with a team led by Daniel Daeniker and Daniel Hasler. The group further comprised IP partner Gregor Bühler, tax partner Stefan Oesterhelt, and financial services partner Daniel Haeberli and counsel Eduard De Zordi.
US boutique SextonRiley, founded by former Ropes & Gray lawyers Mike Sexton and Lindsay Riley, worked on matters from Boston.
The target Actelion meanwhile turned to Slaughter and May partners Simon Nicholls and David Johnson. They were supported on the corporate side by partners Susannah Macknay and Rob Innes.
IP advice was provided by Slaughters partner Susie Middlemiss, with fellow partners Jeanette Zaman and Lisa Wright working on tax and antitrust matters respectively.
The Slaughters team worked alongside Wachtell Lipton Rosen & Katz corporate partners Dan Neff and Greg Ostling. Counsel Franco Castelli advised on antitrust issues, with partners Greg Pessin, Adam Shapiro and Eiko Stange providing restructuring, employee benefits and tax support respectively.
Niederer Kraft & Frey acted as local counsel in Switzerland, with a team led by partners Philipp Haas and Ulysses von Salis. Support was provided by corporate partners Thomas Broennimann and Bertrand Schott, Tax partner Daniela Schmucki, pensions partner Laurence Uttinger and TMT partner Clara-Ann Gordon completed the team.
The deal sees Johnson & Johnson acquire biotechnology company Actelion for $30bn. As part of the transaction, Actelion will spin out its research and development unit into a newly created Swiss biopharmaceutical company.
Background to the deal
Johnson & Johnson regularly uses Cravath on large M&A transactions, with the company acquiring Abbott Laboratories for $4.3bn last year. The firm again acted opposite Wachtell, which advised the target.
Wachtell and Slaughters often work on transactions together, with the latter also co-ordinating deals with US heavyweights such as Cravath and Paul Weiss Rifkind Wharton & Garrison. Slaughters partner Susie Middlemiss is understood to hold the relationship with Actelion, heading up the firm’s pharmaceuticals, biotechnology and healthcare practice.
#1 Lawyers Search Engine